Image

Global Vascular Malformations Drugs Market – Industry Trends and Forecast to 2030

Pharmaceutical

Image

Global Vascular Malformations Drugs Market – Industry Trends and Forecast to 2030

  • Pharmaceutical
  • Upcoming Report
  • Nov 2022
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Vascular Malformations Drugs Market – Industry Trends and Forecast to 2030

Market Size in USD Billion

CAGR :  % Diagram

Diagram Forecast Period 2022–2030
Diagram Market Size (Base Year) USD 2.71 USD Billion
Diagram Market Size (Forecast Year) USD 4.50 USD Billion
Diagram CAGR %

Major Markets Players

  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

Global Vascular Malformations Drugs Market, By Type (Capillary Vascular Malformations, Spider Angiomas, Venous Malformations, Arteriovenous Malformations, Lymphatic Malformations, Pyogenic Granulomas, Angiofibromas, Glomangiomas, Hemangiomas, Others), Drugs (Sirolimus, Sodium Tetradecyl Sulfate (1%), Ethanol (95%), Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2030.

Vascular Malformations Drugs Market

Vascular Malformations Drugs Market Analysis and Size

The global vascular malformations drugs market is expected to witness significant growth during the forecast period. Vascular malformations are congenital vasculogenesis disorders affecting around 0.5% of the population. Although benign, lesions cause major morbidity, primarily because they enlarge over time. The healthcare professionals who focus on patients having vascular malformations recognize that these lesions are not static. The increasing prevalence of chronic diseases, such as cancer and vascular diseases, drives the vascular malformation drug market.

Data Bridge Market Research analyses a growth rate in the global vascular malformations drugs market in 2023-2030. The expected CAGR of the global vascular malformations drugs market tends to be around 6.50% in the mentioned forecast period. The market was valued at USD 2.71 billion in 2022 and would grow to USD 4.50 billion by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Vascular Malformations Drugs Market Scope and Segmentation

Report Metric

Details

Forecast Period

2023 to 2030

Base Year

2022

Historic Years

2021 (Customizable to 2015 - 2020)

Quantitative Units

Revenue in USD Billion, Volumes in Units, Pricing in USD

Segments Covered

Type (Capillary Vascular Malformations, Spider Angiomas, Venous Malformations, Arteriovenous Malformations, Lymphatic Malformations, Pyogenic Granulomas, Angiofibromas, Glomangiomas, Hemangiomas, Others), Drugs (Sirolimus, Sodium Tetradecyl Sulfate (1%), Ethanol (95%), Others), End-Users (Hospitals, Homecare, Speciality Centres, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)

Countries Covered

U.S., Canada, and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Market Players Covered

Galderma (Switzerland), Abbvie, Inc. (U.S.), Bausch Health Companies Inc. (U.S.)., Bristol Myers Squibb Company (U.S.) Fresenius Kabi AG (Germany), Merck KGaA (Germany), Sanofi (France), F. Hoffmann-La Roche Ltd. (Switzerland), Mylan N.V. (U.S.), Teva Pharmaceutical Industries Ltd. (Israel), Sanofi (France), Pfizer Inc. (U.S.), GSK plc (U.K.), Novartis AG (Switzerland), Accord Healthcare (U.K.), Zydus Group (India), Dr Reddy's Laboratories Ltd (India), Amneal Pharmaceuticals LLC. (U.S.), Apotex Inc (Canada)

Market Opportunities

  • Increasing demand for retail pharmacies
  • Varied treatment methods for vascular malformations

Market Definition

Vascular malformations are the kind of birthmark or growth, such as blemish or mass, that may cause pain, swelling, or bleeding. Vascular malformations often result from abnormal development in blood vessels, lymph vessels, veins, and arteries. Vascular malformations are usually present at birth; the abnormalities grow proportionally with the child. Vascular malformations are differentiated from vascular tumors based on endothelial proliferation.

Global Vascular Malformations Drugs Market Dynamics

Drivers

  • Growing cases of vascular malformations

Venous malformation (V.M.) is the most common type of congenital vascular malformation (CVM), with an occurrence of 1 to 2 in 10,000 and an incidence of 1%. Some of its types are found in less than 1 percent of the population. Thus, this boosts market growth.

  • Huge demand for diagnostic tests

The increasing demand for several diagnostic tests such as g ultrasound, MRI, and/or angiography are driving the market's growth. Angiography involves the injection of a dye, which will outline the blood vessels on an X-ray; thus, these diagnostic tests are pushing the market growth.

Opportunities

  • Increasing demand for retail pharmacies

The rise in the number of medications for vascular malformations delivered through these retail pharmacies and the increase in the number of retail pharmacies in highly developed countries create opportunities for market growth. Additionally, patients prefer retail pharmacies for purchasing drugs, as these are easily available.

  • Varied treatment methods for vascular malformations

Diverse treatment methods are working well for the patients, such as embolization, sclerotherapy, laser, and resection, which will create more opportunities for market growth. Sclerotherapy successfully treats varicose and spider veins. It's often considered the ultimate treatment of choice for small varicose veins.

Restraints/Challenges

  • Side effects of vascular malformations drugs

There are several side effects that are associated with vascular malformation drugs. Vascular malformations drugs can lead to headaches, dizziness, vision problems, and seizures which somewhat hamper the market growth.

  • High cost of treatment

The huge expenditure on treatment methods hampers the market growth. Several treatment options, such as varied surgeries and therapies, are not so cost-effective and thus hinder the market's growth.

This global vascular malformations drugs market  report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global vascular malformations drugs market  contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Vascular Malformations Drugs Market Scope

The global vascular malformations drugs market  is segmented on the basis of type, drugs, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Type

  • Capillary Vascular Malformations
  • Spider Angiomas, Venous Malformations
  • Arteriovenous Malformations
  • Lymphatic Malformations
  • Pyogenic Granulomas
  • Angiofibromas
  • Glomangiomas
  • Hemangiomas
  • Others

Drugs

  • Sirolimus
  • Sodium Tetradecyl Sulfate (1%)
  • Ethanol (95%)
  • Others

End-Users

  • Hospitals
  • Homecare
  • Speciality Centres
  • Others

Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

Vascular Malformations Drugs Market Regional Analysis/Insights

The global vascular malformations drugs market  is analysed and market size insights and trends are provided by type, drugs, distribution channel and end-user as referenced above.

The major countries covered in the global vascular malformations drugs market  report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America is expected to have the highest market growth due to increased healthcare and R&D expenditure and the presence of skilled professionals.

Asia-Pacific dominates the market due to increased general skin problems, increased awareness for vascular malformations through advertisement and media, and rapidly improving healthcare infrastructure in the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Competitive Landscape and Global Vascular Malformations Drugs Market Share Analysis

The global vascular malformations drugs market  competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global vascular malformations drugs market.

Key players operating in the global vascular malformations drugs market  include:

  • Galderma (Switzerland)
  • Abbvie, Inc. (U.S.)
  • Bausch Health Companies Inc. (U.S.).
  • Bristol Myers Squibb Company (U.S.)
  • Fresenius Kabi AG (Germany)
  • Merck KGaA (Germany)
  • Sanofi (France)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Mylan N.V. (U.S.),
  • Teva Pharmaceutical Industries Ltd. (Israel)
  • Sanofi (France)
  • Pfizer Inc. (U.S.)
  • GSK plc (U.K.)
  • Novartis AG (Switzerland)
  • Accord Healthcare (U.K.)
  • Zydus Group (India)
  • Dr Reddy's Laboratories Ltd (India)
  • Amneal Pharmaceuticals LLC. (U.S.)
  • Apotex Inc (Canada)


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for Infographics

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Research Methodology:

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

Please fill in the below form for Research Methodology

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Customization Available:

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Please fill in the below form for Available Customization

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

FREQUENTLY ASK QUESTIONS

Vascular Malformations Drugs Market to grow at a CAGR 6.50% by forecast 2030.
Vascular Malformations Drugs Market value to reach USD 4.50 billion by forecast 2030.
The major countries covered in the global vascular malformations drugs market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Free Sample Report

CHOOSE LICENCE TYPE

  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00

Why Choose Us

Industry Coverage

DBMR works across the globe in multiple industries which equip us with knowledge across verticals and provide our clients with insights not only from their industry but how other industries will impact their ecosystem.

Regional Coverage

Coverage of Data Bridge is not restricted to developed or emerging economies. We work across the globe covering the largest array of countries where no other market research or business consulting firm has ever conducted research; creating growth opportunities for our clients in areas which are still unknown.

Technology Coverage

In today’s world, technology drives the market sentiment, so our vision is to provide our clients insights not only for developed technologies but upcoming and disrupting technological changes throughout the product lifecycle by enabling them with unforeseen opportunities in the market which will create disruption in their industry. This leads to innovation and our clients to come out as winners.

Goal Oriented Solutions

DBMR goal is to help our clients achieve their goals through our solutions; hence we formatively create the most appropriate solutions for our client needs, saving time and efforts for them to drive their grand strategies.

Unparallel Analyst Support

Our analysts take pride in our clients’ success. Unlike others, we believe in working along our clients to achieve their goals with 24 hours analyst support determining the correct needs and inspire innovation through service.

Banner

Client Testimonials